Catalent, Moderna expand COVID vaccine manufacturing agreement

10:18 AM, 8th April 2021
Catalent and Moderna came to the decision of extending their COVID vaccine manufacturing agreement after their initial success on reaching the milestone of producing 100 million doses of the vaccine t
Catalent and Moderna came to the decision of extending their COVID vaccine manufacturing agreement after their initial success on reaching the milestone of producing 100 million doses of the vaccine together.

SOMERSET, UK: Catalent and Moderna announced the expansion of their strategic collaborating to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs in Moderna’s pipeline, at Catalent’s biologics facility in Bloomington, Indiana.

The two companies, Catalent and Moderna, in June 2020, announced that Catalent would provide aseptic vial filling and packaging from its Bloomington site, including additional staffing required for 24×7 manufacturing to support production of an initial 100 million doses of Moderna’s vaccine. On March 29, Moderna announced that this significant milestone was achieved.

As a result of their previous successful venture, the companies came to the decision of extending their COVID vaccine manufacturing agreement for an even longer term this time. As part of this expanded agreement, Catalent will now dedicate to Moderna’s use a new high-speed filling line at the site through June 2023, which can be used to manufacture the COVID-19 vaccine and potentially additional investigational programs in Moderna’s large clinical pipeline. Catalent will also provide inspection, labeling, cartoning, and final packaging for these programs.

“We appreciate this expanded collaboration with Catalent and the dedication of their team,” said Juan Andres, Moderna’s chief technical operations and quality officer. “This additional fill-finish capacity will be important for not only our COVID-19 vaccine, but also potentially for other programs in our clinical development pipeline.”

“Catalent’s partnership with Moderna began in 2016, when we had only glimpsed the potential applications of mRNA and could not have guessed how pivotal mRNA would become in the fight against COVID-19,” said Alessandro Maselli, Catalent’s president and chief operating officer. “We are proud to announce this extension of our companies’ strategic collaboration, and we look forward to further demonstrating our commercial manufacturing expertise as we help supply more vaccine doses.”

© Worldofchemicals News

 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Borealis appoints ex-OMV executive board member as CEO

VIENNA, AUSTRIA: The Borealis supervisory board has appointed Thomas Gangl as the new CEO of Borealis AG, effective 1 April 2021. Thomas Gangl succeed ...

Read more
Total starts sustainable aviation fuel production in France

PARIS, FRANCE: Total has started producing sustainable aviation fuel (SAF) at its La Mède biorefinery in southern France and its Oudalle facili ...

Read more
Solvay increases silica products' price globally

BRUSSELS, BELGIUM: Effective 5 April, Solvay has increased the price of its silica products globally. It will implement an across-the-board 10 percent ...

Read more
US trade commission supports SK in LG's battery patent infringement case

SEOUL, SOUTH KOREA: The US International Trade Commission ruled in favor of SK Innovation in its battery patent case against LG Energy Solution, in an ...

Read more
BASF to produce repulpable packaging paper in Shanghai, China

HONG KONG, CHINA: Joncryl High Performance Barrier (HPB) products are water-based film-forming dispersions that provide heat-sealable liquid barrier. ...

Read more
Brenntag, Marigot sign mineral distribution agreement for Denmark

ESSEN, GERMANY: Brenntag Food & Nutrition has signed a new distribution agreement with Marigot for the exclusive distribution of Marigot’s r ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X